Join to View Full Profile
Sleep Wake Disorders Center3411 Wayne Avenue Ground FLBronx, NY 10467
Phone+1 718-920-4841
Fax+1 718-798-4352
Dr. Thorpy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Neurology, 1980 - 1981
SUNY Upstate Medical UniversityResidency, Neurology, 1978 - 1980
University of Otago School of MedicineClass of 1973
Certifications & Licensure
NY State Medical License 1980 - 2027
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy
- A Study to Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy Start of enrollment: 2019 Sep 21
Publications & Presentations
PubMed
- How once-nightly sodium oxybate is processed in the body in healthy volunteers: a plain language summary.Richard Bogan, Michael J Thorpy, Sarah Berkowitz, Jennifer Gudeman
Journal of Comparative Effectiveness Research. 2025-03-28 - 1 citationsEfficacy of Once-Nightly Sodium Oxybate in Patients with Narcolepsy: Post Hoc Analyses of Sensitivity, Effect Size, and Numbers Needed to Treat from the Phase 3 REST-O...Thomas Roth, Michael J Thorpy, Clete A Kushida, Jennifer Gudeman
CNS Drugs. 2025-03-01 - A New Dawn in the Management of Narcolepsy.Michael J Thorpy, Anne Marie Morse
CNS Drugs. 2025-03-01
Press Mentions
Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with Narcolepsy and Their CliniciansMarch 25th, 2025- Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with Narcolepsy and Their CliniciansMarch 25th, 2025
- Investigational AXS-12 Reduces Cataplexy in Narcolepsy PatientsNovember 26th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
